Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LEAH LANDE

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1164457602
CMS profile
233990
Location
WYNNEWOOD, PA

General Payments · PY2018–2024

$1,429.18

  • Reported across 71 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$383.08

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $383.08 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $154.00 7
ABBVIE INC. $92.34 4
Insmed, Inc. $69.57 2
Electromed, Inc. $45.15 1
Relypsa, Inc. $22.02 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $208.78 13
PY2019 $162.56 9
PY2020 $31.83 2
PY2021 $229.65 11
PY2022 $209.03 11
PY2023 $204.25 10
PY2024 $383.08 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.34 01/17/2024 Food and Beverage Undisputed 01/23/2026 1104134150 CMS
ABBVIE INC. $24.90 04/01/2024 Food and Beverage Undisputed 01/23/2026 1104134152 CMS
ABBVIE INC. $20.13 05/08/2024 Food and Beverage Undisputed 01/23/2026 1104134154 CMS
ABBVIE INC. $20.97 05/08/2024 Food and Beverage Undisputed 01/23/2026 1104134156 CMS
Electromed, Inc. $45.15 11/13/2024 Food and Beverage Undisputed 01/23/2026 1137899997 CMS
GlaxoSmithKline, LLC. $20.83 01/17/2024 Food and Beverage Undisputed 01/23/2026 1116708395 CMS
GlaxoSmithKline, LLC. $22.06 01/23/2024 Food and Beverage Undisputed 01/23/2026 1115932233 CMS
GlaxoSmithKline, LLC. $23.31 03/11/2024 Food and Beverage Undisputed 01/23/2026 1116259573 CMS
GlaxoSmithKline, LLC. $20.87 04/22/2024 Food and Beverage Undisputed 01/23/2026 1116668804 CMS
GlaxoSmithKline, LLC. $24.04 05/07/2024 Food and Beverage Undisputed 01/23/2026 1116313717 CMS
GlaxoSmithKline, LLC. $20.35 07/23/2024 Food and Beverage Undisputed 01/23/2026 1116568863 CMS
GlaxoSmithKline, LLC. $22.54 09/13/2024 Food and Beverage Undisputed 01/23/2026 1116450935 CMS
Insmed, Inc. $34.65 02/12/2024 Food and Beverage Undisputed 01/23/2026 1089572882 CMS
Insmed, Inc. $34.92 07/18/2024 Food and Beverage Undisputed 01/23/2026 1089560668 CMS
Vifor Pharma, Inc. $22.02 12/09/2024 Food and Beverage Undisputed 01/23/2026 1124062446 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.